Barclays analyst Steve Valiquette raised the firm’s price target on AmerisourceBergen to $189 from $182 and keeps an Overweight rating on the shares. Core strength drove the company’s beat and raise fiscal Q2, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABC:
- AmerisourceBergen raises FY23 EPS view to $11.70-$11.90 from $11.50-$11.75
- AmerisourceBergen reports Q2 adjusted EPS $3.50, consensus $3.29
- ABC Upcoming Earnings Report: What to Expect?
- TPG, AmerisourceBergen to acquire OneOncology in $2.1B transaction
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
